Analyzing Cancer Cells to Choose Treatments
September 30, 2009
Microfluidics chips allow scientists to study circulating cancer cells and determine their vulnerabilities.
By Emily Singer from MIT Technology Review
In a new clinical trial for prostate cancer, scientists will capture rare tumor cells circulating in patients’ blood, analyze them using a specialized microchip, and use the results to try to predict how well the patient will respond to a drug. The trial reflects a new phase of personalized medicine for cancer, enabled by microfluidics technologies that can isolate scarce cancer cells and detect very small changes in gene expression. Read more
Microchip spots cancer quickly and painlessly
September 28, 2009
by Megan Ogilvie & Joseph Hall
Toronto Star
Toronto researchers have developed a portable device they say will accurately diagnose prostate cancer in 30 minutes. Read more